Medtronic Arctic Front Advance Cardiac Cryoablation Device 28mm x 134cm, 13.5mm Distal Tip
In Stock: 2 Eaches
Express: Need it tomorrow? Order in next 2 hours 8 minutes and choose overnight shipping at checkout.
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in-date item only.
Description
Medtronic Arctic Front Advance Cryoablation Device
The Arctic Front Advance™ over-the-wire balloon catheter is designed to enable pulmonary vein isolation (PVI) during atrial fibrillation ablation procedures.
The Arctic Front Advance™ over-the-wire balloon catheter is part of a family of cryoballoon catheters designed for use with the Achieve™ mapping catheters, the FlexCath Contour™ steerable sheath, the FlexCath Cross™ transeptal solution, and the CryoConsole™ cardiac cryoablation system. More than 1.4 million patients worldwide have been treated with the Medtronic cryoballoon.
Arctic Front Advance™ features temperature uniformity with EvenCool™ cryo technology enabling contiguous lesions.
Product Code 2AF284
- Size: 28mm
- Catheter Size OD: 10.5F
- Overall Length: 134cm
- Effective Length: 95cm (+/- 2cm)
- Distal Tip Length: 13.5mm
- Recommended introducer sheath: Compatible Medtronic 12 Fr inner diameter sheath (FlexCath Contour™ steerable sheath)
- Guidewire compatibility: 0.032"-0.035"
- Deflection: Bidirectional 45°
- Tip and Shaft Material: Biocompatible copolymer (Pebax™) with barium sulfate blend (BaSO4)
- Outer Balloon Material: Polyurethane
Additional information
| Size | 1 |
|---|---|
| Arms | N/A |
| Manufacturer | |
| Unit | box of 1 |
- FDA Product Code: OAE
- FDA Product Code Name: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
- GMDN Term Code: 60720
- GMDN Term Name: Cardiac cryosurgical system catheter
- GMDN Term Description: A sterile, flexible device intended to be used as part of a cardiac tissue cryosurgical system to cryogenically ablate areas of the endocardium of a beating heart in the treatment of cardiac arrhythmias. It is intended to be introduced into the heart via venous access (e.g., femoral vein) and deliver pressurized liquid refrigerant (e.g., nitrous oxide) to its distal cooling segment to achieve extremely low temperatures through gas expansion; it typically includes sensors (e.g., temperature monitoring). This is a single-use device.
